Showing results (371-380 of 1,349) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|July 4, 2019
A Randomized, Placebo-Controlled Trial to Assess the Effects of 8 Weeks of Administration of GSK256073, a Selective GPR109A Agonist, on High-Density Lipoprotein Cholesterol in Subjects With DyslipidemiaEric J Olson, Kelly M Mahar, Thomas F Haws, et al.
Clinical Pharmacology in Drug Development|July 10, 2019
A First-in-Human Clinical Study With TRV734, an Orally Bioavailable G-Protein-Biased Ligand at the μ-Opioid ReceptorIan E James, Franck Skobieranda, David G Soergel, et al.
Clinical Pharmacology in Drug Development|July 10, 2019
Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy VolunteersMeera Tugnait, Neeraj Gupta, Michael J Hanley, et al.
Clinical Pharmacology in Drug Development|October 15, 2019
A Pharmacokinetic Bioequivalence Study Comparing Sublingual Riluzole (BHV-0223) and Oral Tablet Formulation of Riluzole in Healthy VolunteersIrfan Qureshi, Meghan Lovegren, Victoria Wirtz, et al.
Clinical Pharmacology in Drug Development|June 29, 2019
A First-in-Human Phase 1 Randomized Single and Multiple Ascending Dose Study of RPh201 in Healthy VolunteersZadik Hazan, Konstantin Adamsky, Andre Lucassen, et al.
Clinical Pharmacology in Drug Development|February 22, 2022
Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Isavuconazonium Sulfate in Healthy Adult Japanese SubjectsShinichiro Shirae, Atsushi Ose, Yuji Kumagai
Clinical Pharmacology in Drug Development|February 16, 2022
Effect of Phosphate Binders and a Dietary Iron Supplement on the Pharmacokinetics of a Single Dose of Vadadustat in Healthy AdultsSusan K Paulson, Jimena Martinez, Rishikesh Sawant, et al.
Clinical Pharmacology in Drug Development|February 19, 2022
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Insulin Administration in Healthy Subjects: A Randomized, Double-Blind, Phase 1 TrialYifei Zhang, Weiwei Zhou, Liyun Shen, et al.
Clinical Pharmacology in Drug Development|February 19, 2022
A Phase 1 Clinical Study Evaluating the Effects of Cenobamate on the QT IntervalBorje Darpo, Philip T Sager, Hongqi Xue, et al.
Clinical Pharmacology in Drug Development|January 29, 2022
Population Pharmacokinetics Analysis of Pemigatinib in Patients With Advanced MalignanciesTao Ji, Xuejun Chen, Xiang Liu, et al.
Pageof 135